Anúncio
Anúncio
GOSS
Gossamer Bio, Inc. Common Stock
2.50
USDPatrocinado
0.00
+0.20%
09 de jan., 15:58 UTC -5
Encerrado
Pós-Mercado
2.52
+0.02
+0.60%
Relatórios de Lucros GOSS
Rácio de surpresa positiva
GOSS separação 14 de 28 últimas estimativas.
50%
Próximo Relatório
Data do Próximo Relatório
11 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$7.67M
/-$0.18
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-42.28%
/-14.29%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-18.19%
/+20.00%
Gossamer Bio, Inc. Common Stock earnings per share and revenue
On 05 de nov. de 2025, GOSS reported earnings of -0.21 USD per share (EPS) for Q3 25, missing the estimate of -0.19 USD, resulting in a -7.36% surprise. Revenue reached 13.29 milhão, compared to an expected 6.46 milhão, with a 105.88% difference. The market reacted with a -2.53% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analistas forecast an EPS of -0.18 USD, with revenue projected to reach 7.67 milhão USD, implying an diminuir of -14.29% EPS, and diminuir of -42.28% in Revenue from the last quarter.
FAQ
What were Gossamer Bio, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Gossamer Bio, Inc. Common Stock reported EPS of -$0.21, missing estimates by -7.36%, and revenue of $13.29M, 105.88% above expectations.
How did the market react to Gossamer Bio, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.53%, changed from $2.37 before the earnings release to $2.31 the day after.
When is Gossamer Bio, Inc. Common Stock expected to report next?
The next earning report is scheduled for 11 de mar. de 2026.
What are the forecasts for Gossamer Bio, Inc. Common Stock's next earnings report?
Based on 10
analistas, Gossamer Bio, Inc. Common Stock is expected to report EPS of -$0.18 and revenue of $7.67M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio